Hanoch Rappaport
Chief Executive Officer at Provident Fund of the Hebrew University of Jerusalem Ltd.
Hanoch Rappaport active positions
| Companies | Position | Start | End |
|---|---|---|---|
| The Hebrew University of Jerusalem | Corporate Officer/Principal | - | - |
| Provident Fund of the Hebrew University of Jerusalem Ltd. | Chief Executive Officer | 31/12/2013 | - |
| Director of Finance/CFO | 30/04/2005 | 31/12/2013 |
Career history of Hanoch Rappaport
Former positions of Hanoch Rappaport
| Companies | Position | Start | End |
|---|---|---|---|
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Director/Board Member | 31/12/2005 | 31/10/2013 |
| ANCHIANO THERAPEUTICS LTD. | Director/Board Member | 31/12/2005 | - |
| A. Heifetz & Co. | Chief Investment Officer | - | - |
| BANK HAPOALIM B.M. | Corporate Officer/Principal | - | - |
Training of Hanoch Rappaport
| Tel-Aviv University | Masters Business Admin |
| The Hebrew University of Jerusalem | Masters Business Admin |
| Bar-Ilan University | Undergraduate Degree |
Statistics
International
| Israel | 7 |
| United States | 3 |
Operational
| Director/Board Member | 2 |
| Masters Business Admin | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Consumer Services | 4 |
| Finance | 3 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BANK HAPOALIM B.M. | Finance |
| Private companies | 4 |
|---|---|
Anchiano Therapeutics Ltd.
 Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel. | Health Technology |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
| A. Heifetz & Co. | |
| Provident Fund of the Hebrew University of Jerusalem Ltd. | Finance |
- Stock Market
- Insiders
- Hanoch Rappaport
- Experience